Clinical Trial Update: Safety and Efficacy of Intravenous ACZ885 and Oral Methotrexate Therapy in Patients With Early Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

Phase 2 study evaluating the safety and efficacy of intravenous ACZ885 in combination with oral methotrexate for patients with early rheumatoid arthritis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ACZ885 (canakinumab)
• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Novartis | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED | Results posted: 2011-05-06